Cancer, Lung Clinical Trial
Official title:
A Brief Messaging Lifestyle Modification Program for Patients With Non-small Cell Lung Cancer - A Pilot Study
Lung cancer is one of the most common cancer diseases, globally and locally. Several health
benefits of increased physical activity (PA) have been reported for people with cancer. PA
plays a critical role across the cancer trajectory, from prevention through to post-diagnosis
and has been proposed as an alternative for improving physical and psychosocial health
outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality.
Although there are a variety of exercise intervention programs for cancer patients, those
programs were quite intensive, requiring individuals to commit extra time and effort. Feeling
of overwhelmed appointments, lack of time, other barriers, including high cost and limited
access to facilities are the most frequently reported barriers that prevent people from
starting and maintaining exercise. Hence, the investigators propose to use a brief messaging
lifestyle modification intervention program to incorporating simple and easy-to-do
patient-centred home-based lifestyle-integrated exercise into daily activities of patients
with lung cancer. The aims are to increase patients' physical activity and improve their
fatigue, emotion and quality of life, compared to the control group.
Status | Recruiting |
Enrollment | 32 |
Est. completion date | May 30, 2021 |
Est. primary completion date | April 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Aged 18 years and above; - Diagnosis with non-small cell lung cancer - General condition stable, either is undergoing or finished treatment - Able to speak and read Chinese - Able to complete the self-administered questionnaire - Able to use instant messages such as WhatsApp or WeChat - Mental, cognitive and physically fit determined by the clinicians/investigators - Signed informed consent Exclusion Criteria: - Pre-operative lung cancer - Skeletal fragility - Serious active infection - Inability to walk - Previously untreated symptomatic brain metastases - Severe respiratory insufficiency - Uncontrolled pain |
Country | Name | City | State |
---|---|---|---|
Hong Kong | Agnes | Hong Kong | |
Hong Kong | Queen Mary Hospital | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
The University of Hong Kong |
Hong Kong,
Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985 Mar-Apr;100(2):126-31. — View Citation
Peddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galvão DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev. 2019 Feb 11;2:CD012685. doi: 10.1002/14651858.CD012685.pub2. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in fatigue level at 6 weeks | measured by Brief Fatigue Inventory | Baseline and 6 weeks | |
Secondary | Change in physical activity at 6 weeks | measured by International Physical Assessment Questionnaire - Short version | Baseline and 6 weeks | |
Secondary | Change in health-related quality of life at 6 weeks | measured by European Organisation for Research and Treatment of Cancer and lung module questionnaire | Baseline and 6 weeks | |
Secondary | Change in functional level at 6 weeks | measured by Functional Assessment Cancer Therapy - Lung (FACT-L) questionnaire | Baseline and 6 weeks | |
Secondary | Change in anxiety and depression symptoms at 6 weeks | measured by Hospital Anxiety and Depression Scale. Each item is answered on a 4-point scale (0-3). The scores for the seven questions on depression are added together to obtain a score ranged from 0 to 21. The higher score the more depressed. The scores for the seven questions on anxiety are added together to obtain a score ranged from 0 to 21. The higher score the more anxiety. | Baseline and 6 weeks | |
Secondary | Change in insomnia level at 6 weeks | measured by Insomnia Severity Index | Baseline and 6 weeks | |
Secondary | Change in sleep quality at 6 weeks | measured by Pittsburgh Sleep Quality Index | Baseline and 6 weeks | |
Secondary | Change in excessive daytime sleepiness at 6 weeks | measured by Epworth Sleepiness Scale. It is a scale of increasing probability from 0 to 3 for eight different situations that most people engage in during their daily lives, though not necessarily every day. The scores for the eight questions are added together to obtain a score ranged from 0 to 24. The higher score the more sleepiness. | Baseline and 6 weeks | |
Secondary | Change in activity level at 6 weeks | measured by fitbits | Baseline and 6 weeks | |
Secondary | Change in hand grips strength at 6 weeks | measured by a dynamometer | Baseline and 6 weeks | |
Secondary | Change in lower limb strength at 6 weeks | assessed by using a 30-second chair stand test to record the number of stands from chair in 30 seconds | Baseline and 6 weeks | |
Secondary | Change in balance at 6 weeks | assessed by a single-leg-stance test by recording the time within which the individual could effectively achieve balance on one leg | Baseline and 6 weeks | |
Secondary | Change in flexibility at 6 weeks | assessed by chair sit and reach test | Baseline and 6 weeks | |
Secondary | Change in endurance at 6 weeks | assessed by 6-minute walk | Baseline and 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06152419 -
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
|
N/A | |
Completed |
NCT05732350 -
Exploratory Drug Interaction Study Between SMIs and DOACs
|
||
Active, not recruiting |
NCT04300244 -
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
|
Phase 2 | |
Recruiting |
NCT05311709 -
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
|
Phase 2 | |
Active, not recruiting |
NCT04396457 -
Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901
|
Phase 2 | |
Recruiting |
NCT06391749 -
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
|
||
Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
Recruiting |
NCT03301493 -
Genomic Testing and Resulting Medical Decisions
|
||
Completed |
NCT04788147 -
Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)
|
N/A | |
Not yet recruiting |
NCT06035731 -
Evaluation of the Medical Service by Socio-aesthetics in Oncology
|
N/A | |
Recruiting |
NCT03274349 -
Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma
|
N/A | |
Recruiting |
NCT05830097 -
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02991677 -
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
|
N/A | |
Completed |
NCT04971304 -
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
|
||
Recruiting |
NCT04859400 -
Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients
|
N/A | |
Recruiting |
NCT05948865 -
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
|
Phase 1 | |
Recruiting |
NCT04270890 -
Investigation of an Abdominal Compression Device
|
N/A | |
Not yet recruiting |
NCT05154474 -
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
|
||
Not yet recruiting |
NCT05857995 -
Precision Lung Cancer Survivorship Care Intervention
|
N/A | |
Not yet recruiting |
NCT03622528 -
Quantitative Lung Cancer Screening
|